Trial Profile
A phase I trial of RG 7713 in autism spectrum disorder
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2015
Price :
$35
*
At a glance
- Drugs RG 7713 (Primary)
- Indications Autistic disorder
- Focus Therapeutic Use
- 06 Nov 2015 New trial record